News
- Author:
- Miriam E. Tucker
Publish date: May 15, 2020
Wuhan researchers found preexisting type 2 diabetes worsened prognosis of COVID-19; but those whose glucose stayed “in-range” had better outcomes.<...
News
- Author:
- Miriam E. Tucker
Publish date: May 15, 2020
Once pandemic restrictions are lifted, comorbidities should factor into which eligible patients should be the fir...
News
- Author:
- Miriam E. Tucker
Publish date: May 7, 2020
Diabetes UK’s COVID-19 task force addresses inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when IVs are unavaila...
News
- Author:
- Miriam E. Tucker
Publish date: May 1, 2020
Some question the safety of AstraZeneca’s just-launched DARE-19 study testing whether dapagliflozin will reduce a...
News
- Author:
- Miriam E. Tucker
Publish date: April 20, 2020
Current American Thyroid Association guidelines strongly suggest the use of levothyroxine over desiccated thyroid extract as thyroid replacement th...
News
- Author:
- Miriam E. Tucker
Publish date: April 2, 2020
Researchers report more than double the rate of hypothyroidism and more than triple the rate of hyperthyroidism, compared with rates in published t...
News
- Author:
- Miriam E. Tucker
Publish date: April 2, 2020
Loss of the glands could serve as a diabetes biomarker, particularly in underserved areas where A1c testing might not be readily available.
News
- Author:
- Miriam E. Tucker
Publish date: April 2, 2020
Virtual press briefings were held on March 30 and 31.
News
- Author:
- Miriam E. Tucker
Publish date: March 18, 2020
The immune attack may be more aggressive and the islets more inflamed in the younger-onset T1DE1 group and less intense in the older-onset T1DE2 gr...
News
- Author:
- Miriam E. Tucker
Publish date: March 16, 2020
European Society of Cardiology cites lack of data for theoretical link between ACE inhibitors and ARBs with COVID-19 infection risk.
News
- Author:
- Miriam E. Tucker
Publish date: March 12, 2020
The draft guidance will replace the requirement that manufacturers conduct cardiovascular outcomes trials to rule out unacceptable cardiovascular s...
News
- Author:
- Miriam E. Tucker
Publish date: March 10, 2020
The society is currently “exploring ways in which we might be able to deliver to our registrants content from ENDO 2020 in various venues in the co...
News
- Author:
- Miriam E. Tucker
Publish date: March 7, 2020
Presence of periodontal disease and an increased number of missing teeth may be augmenting factors.
News
- Author:
- Miriam E. Tucker
Publish date: March 5, 2020
Empagliflozin and dulaglutide were the most-prescribed drugs in their respective classes for treating type 2 diabetes over 5 years.
News
- Author:
- Miriam E. Tucker
Publish date: January 24, 2020
Government reforms and the involvement of nongovernmental organizations in price oversight and generic manufacturing are among the possible solutio...
